158 related articles for article (PubMed ID: 24668138)
1. Chronic kidney disease after autologous stem cell transplantation: analysis of a single center experience.
Wu Q; Li X; Lai Y; Peng Z; Liao Y
Int Urol Nephrol; 2014 Jul; 46(7):1403-10. PubMed ID: 24668138
[TBL] [Abstract][Full Text] [Related]
2. Chronic Kidney Disease in Long-Term Survivors after Allogeneic Hematopoietic Stem Cell Transplantation: Retrospective Analysis at a Single Institute.
Jo T; Arai Y; Kondo T; Kitano T; Hishizawa M; Yamashita K; Takaori-Kondo A
Biol Blood Marrow Transplant; 2017 Dec; 23(12):2159-2165. PubMed ID: 28822830
[TBL] [Abstract][Full Text] [Related]
3. Chronic kidney disease ten years after pediatric allogeneic hematopoietic stem cell transplantation.
Lugthart G; Jordans CCE; de Pagter APJ; Bresters D; Jol-van der Zijde CM; Bense JE; van Rooij-Kouwenhoven RWG; Sukhai RN; Louwerens M; Dorresteijn EM; Lankester AC
Kidney Int; 2021 Oct; 100(4):906-914. PubMed ID: 34102218
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic analysis of renal biopsies after haematopoietic stem cell transplantation.
Chan GS; Lam MF; Au WY; Chim S; Tse KC; Lo SH; Fung SH; Lai KN; Chan KW
Nephrology (Carlton); 2008 Jun; 13(4):322-30. PubMed ID: 18221254
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors for Acute Kidney Injury and Chronic Kidney Disease following Allogeneic Hematopoietic Stem Cell Transplantation for Hematopoietic Malignancies.
Sakaguchi M; Nakayama K; Yamaguchi H; Mii A; Shimizu A; Inai K; Onai D; Marumo A; Omori I; Yamanaka S; Fujiwara Y; Fukunaga K; Ryotokuji T; Hirakawa T; Okabe M; Tamai H; Okamoto M; Wakita S; Yui S; Tsuruoka S; Inokuchi K
Acta Haematol; 2020; 143(5):452-464. PubMed ID: 31822013
[TBL] [Abstract][Full Text] [Related]
6. Chronic graft-versus-host disease of the kidney in patients with allogenic hematopoietic stem cell transplant.
Fraile P; Vazquez L; Caballero D; Garcia-Cosmes P; López L; San Miguel J; Tabernero JM
Eur J Haematol; 2013 Aug; 91(2):129-34. PubMed ID: 23710658
[TBL] [Abstract][Full Text] [Related]
7. Stable renal function in children and adolescents with sickle cell disease after nonmyeloablative hematopoietic stem cell transplantation.
Pedersen SJV; Monagel DA; Mammen C; Lewis VA; Guilcher GMT; Bruce AA
Pediatr Blood Cancer; 2020 Sep; 67(9):e28568. PubMed ID: 32672896
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological features and prognosis of kidney injury in patients after hematopoietic stem cell transplantation].
Huang H; Xu R
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Jun; 57(6):918-922. PubMed ID: 37357213
[TBL] [Abstract][Full Text] [Related]
9. Long-term renal function after allogenic haematopoietic stem cell transplantation in adult patients: a single-centre study.
Touzot M; Elie C; van Massenhove J; Maillard N; Buzyn A; Fakhouri F
Nephrol Dial Transplant; 2010 Feb; 25(2):624-7. PubMed ID: 19828460
[TBL] [Abstract][Full Text] [Related]
10. [The clinical analysis of nephrotic syndrome after allogeneic hematopoietic stem cell transplantation in one single center].
Chen Y; Huang XJ; Zhang XH; Liu DH; Chen H; Han W; Wang JZ; Chen YH; Wang Y; Wang FR; Zhao T; Liu KY; Xu LP
Zhonghua Nei Ke Za Zhi; 2011 Jul; 50(7):572-5. PubMed ID: 22041267
[TBL] [Abstract][Full Text] [Related]
11. Quiz Page May 2017: CKD and Nephrotic Syndrome After Allogeneic Hematopoietic Cell Transplantation.
Hogan JJ; Palmer MD; Loren AW; Laskin BL
Am J Kidney Dis; 2017 May; 69(5):A10-A13. PubMed ID: 28434525
[No Abstract] [Full Text] [Related]
12. Chronic kidney disease after hematopoietic cell transplantation: frequency, risk factors, and outcomes.
Saddadi F; Hakemi M; Najafi I; Moghadam K; Ghavamzadeh A; Jahani M; Ganji M; Amini M; Soleimanian T
Transplant Proc; 2009 Sep; 41(7):2895-7. PubMed ID: 19765466
[TBL] [Abstract][Full Text] [Related]
13. Long-term renal outcome after allogeneic hemopoietic stem cell transplant: A comprehensive analysis of risk factors in an Asian patient population.
Zhou W; Sultana R; Diong C; Goh YT; Gopalakrishnan S; Ho A; Hwang W; Koh LP; Koh M; Loh Y; Tan P; Linn YC
Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28135776
[TBL] [Abstract][Full Text] [Related]
14. Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation.
Abboud I; Porcher R; Robin M; de Latour RP; Glotz D; Socié G; Peraldi MN
Biol Blood Marrow Transplant; 2009 Oct; 15(10):1251-7. PubMed ID: 19747632
[TBL] [Abstract][Full Text] [Related]
15. Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.
Cavo M; Gay F; Beksac M; Pantani L; Petrucci MT; Dimopoulos MA; Dozza L; van der Holt B; Zweegman S; Oliva S; van der Velden VHJ; Zamagni E; Palumbo GA; Patriarca F; Montefusco V; Galli M; Maisnar V; Gamberi B; Hansson M; Belotti A; Pour L; Ypma P; Grasso M; Croockewit A; Ballanti S; Offidani M; Vincelli ID; Zambello R; Liberati AM; Andersen NF; Broijl A; Troia R; Pascarella A; Benevolo G; Levin MD; Bos G; Ludwig H; Aquino S; Morelli AM; Wu KL; Boersma R; Hajek R; Durian M; von dem Borne PA; Caravita di Toritto T; Zander T; Driessen C; Specchia G; Waage A; Gimsing P; Mellqvist UH; van Marwijk Kooy M; Minnema M; Mandigers C; Cafro AM; Palmas A; Carvalho S; Spencer A; Boccadoro M; Sonneveld P
Lancet Haematol; 2020 Jun; 7(6):e456-e468. PubMed ID: 32359506
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological analysis of allogeneic hematopoietic stem cell transplantation-related membranous glomerulonephritis.
Hiramatsu R; Ubara Y; Sawa N; Hasegawa E; Kawada M; Imafuku A; Sumida K; Mise K; Yamanouchi M; Ueno T; Sekine A; Hayami N; Suwabe T; Hoshino J; Takaichi K; Ohashi K; Fujii T; Wake A; Taniguchi S
Hum Pathol; 2016 Apr; 50():187-94. PubMed ID: 26997455
[TBL] [Abstract][Full Text] [Related]
17. Membranous nephropathy succeeding autologous hematopoietic stem cell transplant: a case report.
Mrabet S; Aicha NB; Abdessayed N; Mokni M; Achour A
BMC Nephrol; 2018 Mar; 19(1):57. PubMed ID: 29523091
[TBL] [Abstract][Full Text] [Related]
18. Post-allogeneic haematopoietic stem cell transplantation membranous nephropathy: clinical presentation, outcome and pathogenic aspects.
Terrier B; Delmas Y; Hummel A; Presne C; Glowacki F; Knebelmann B; Combe C; Lesavre P; Maillard N; Noël LH; Patey-Mariaud de Serre N; Nusbaum S; Radford I; Buzyn A; Fakhouri F
Nephrol Dial Transplant; 2007 May; 22(5):1369-76. PubMed ID: 17255123
[TBL] [Abstract][Full Text] [Related]
19. Independent risk factors and long-term outcomes for acute kidney injury in pediatric patients undergoing hematopoietic stem cell transplantation: a retrospective cohort study.
Hirano D; Kakegawa D; Miwa S; Umeda C; Takemasa Y; Tokunaga A; Kawakami Y; Ito A
BMC Nephrol; 2020 Aug; 21(1):373. PubMed ID: 32854640
[TBL] [Abstract][Full Text] [Related]
20. [Clinical analysis of late-onset nephrotic syndrome after allogenic hematopoietic stem cell transplantation].
Luo XD; Liu QF; Ning J; Wei YQ; Fan ZP; Zhang Y; Sun J
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(46):3280-3. PubMed ID: 18396625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
